Prescription drug

GLP-1 agonists (semaglutide and similar)

Prescription drug.

How to take it

There is no established standard dose for this case; it is advisable to consult a professional.

Effect by goal · level of evidence

Dementia in type 2 diabetes

reduces Moderate study (A)

Pooled data from trials (15,820) and a Danish registry (120,054): GLP-1 agonists were associated with a lower incidence of dementia in people with type 2 diabetes. It strengthens their interest beyond weight and blood sugar; prescription drug.

View the study (study) →

In depth

Drug · Highest evidence: Moderate · 1 finding

Findings

Dementia in type 2 diabetes — reduces (Moderate, study). Pooled data from trials (15,820) and a Danish registry (120,054): GLP-1 agonists were associated with a lower incidence of dementia in people with type 2 diabetes. It reinforces their interest beyond weight and sugar; prescription drug. 35229024

Information, not medical advice. Prescription drugs require a doctor.

Information, not medical advice. Scientific evidence reflects the quality of the studies.